Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N’-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism-Reference-Cited by-同舟云学术

Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N’-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism

Published:2013-07-25 Issue:7 Volume:8 Page:e69420
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nagy Lilla,Docsa Tibor,Szántó Magdolna,Brunyánszki Attila,Hegedűs Csaba,Márton Judit,Kónya Bálint,Virág László,Somsák László,Gergely Pál,Bai Péter

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Critical nodes in signalling pathways: insights into insulin action;CM Taniguchi;Nat Rev Mol Cell Biol,2006

2. Control of glycogen synthesis in health and disease;W Stalmans;Diabetes Metab Rev,1987

3. Short-term hormonal control of protein phosphatases involved in hepatic glycogen metabolism;W Stalmans;Adv Enzyme Regul,1990

4. Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1;T Zhang;Cell Metab,2012

5. Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis;S Aiston;J Biol Chem,2001

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of hormones insulin and glucagon on ubiquitin modifications elucidated by proteomics in liver cells;Life Sciences;2023-09

2. Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity;Medicina;2023-02-07

3. Role of Bioactive Phytoconstituents as Modulators of Hepatic Carbohydrates Metabolising Enzymes: A Target Specific Approach to Treat Diabetes Mellitus;Current Diabetes Reviews;2022-11

4. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity;Future Medicinal Chemistry;2021-05

5. Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors;Pharmaceuticals;2021-04-15